WARNING: Cutting WEIGHT with the help of MEDICATION [diuretics] is DOPING!!

The number of doping cases that can be traced back to the abuse of diuretics has been increased in Ju-Jitsu.

DIURETICS are Doping No. 1 in Ju-Jitsu in 2024

all findings will be investigated and get sanctioned most time with a 4 year ban from competition

Forbidden All times


All prohibited substances in this class are Specified Substances.

All diuretics and masking agents, including all optical isomers, e.g. d- and l- where relevant, are prohibited.

Including, but not limited to:

  • Diuretics such as:
    • Acetazolamide; amiloride; bumetanide; canrenone; chlortalidone; etacrynic acid; furosemide; indapamide; metolazone; spironolactone; thiazides, e.g. bendroflumethiazide, chlorothiazide and hydrochlorothiazide; torasemide; triamterene;
    • Vaptans, e.g. conivaptan, mozavaptan, tolvaptan;
    • Plasma expanders by intravenous administration such as: Albumin, dextran, hydroxyethyl starch, mannitol;
    • Desmopressin;
    • Probenecid;

and other substances with a similar chemical structure or similar biological effect(s).


  • Drospirenone; pamabrom; and topical ophthalmic administration of carbonic anhydrase inhibitors (e.g. dorzolamide, brinzolamide)
  • Local administration of felypressin in dental anaesthesia



The detection in an Athlete’s Sample at all times or In-Competition, as applicable, of any quantity of the following substances subject to threshold limits: formoterol, salbutamol, cathine, ephedrine, methylephedrine and pseudoephedrine, in conjunction with a diuretic or masking agent (except topical ophthalmic administration of a carbonic anhydrase inhibitor or local administration of felypressin in dental anaesthesia), will be considered as an Adverse Analytical Finding (AAF) unless the Athlete has an approved Therapeutic Use Exemption (TUE) for that substance in addition to the one granted for the diuretic or masking agent.